| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/31/2022 | 121.4% | Piper Sandler | → $6 | Initiates Coverage On | → Overweight |
| 08/22/2022 | -26.2% | Goldman Sachs | → $2 | Downgrades | Neutral → Sell |
| 05/09/2022 | 342.8% | HC Wainwright & Co. | $15 → $12 | Maintains | Buy |
| 03/14/2022 | 453.51% | HC Wainwright & Co. | $24 → $15 | Maintains | Buy |
| 01/20/2021 | 195.2% | Baird | → $8 | Downgrades | Outperform → Underperform |
| 01/20/2021 | 785.61% | HC Wainwright & Co. | $16 → $24 | Maintains | Buy |
| 07/14/2020 | 527.31% | BTIG | $31 → $17 | Maintains | Buy |
| 07/26/2019 | 527.31% | Baird | → $17 | Initiates Coverage On | → Outperform |
| 03/15/2019 | 638.01% | Raymond James | → $20 | Initiates Coverage On | → Outperform |
| 03/07/2019 | 527.31% | HC Wainwright & Co. | → $17 | Initiates Coverage On | → Buy |
| 10/23/2018 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 10/23/2018 | 564.21% | Goldman Sachs | → $18 | Initiates Coverage On | → Neutral |
| 10/23/2018 | 859.41% | BTIG | → $26 | Initiates Coverage On | → Buy |
| 10/23/2018 | 822.51% | Barclays | → $25 | Initiates Coverage On | → Overweight |
Gritstone Bio Questions & Answers
The latest price target for Gritstone Bio (NASDAQ: GRTS) was reported by Piper Sandler on October 31, 2022. The analyst firm set a price target for $6.00 expecting GRTS to rise to within 12 months (a possible 121.40% upside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for Gritstone Bio (NASDAQ: GRTS) was provided by Piper Sandler, and Gritstone Bio initiated their overweight rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Gritstone Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Gritstone Bio was filed on October 31, 2022 so you should expect the next rating to be made available sometime around October 31, 2023.
While ratings are subjective and will change, the latest Gritstone Bio (GRTS) rating was a initiated with a price target of $0.00 to $6.00. The current price Gritstone Bio (GRTS) is trading at is $2.71, which is within the analyst's predicted range.